Brief Article
Copyright ©2012 Baishideng Publishing Group Co.
World J Gastroenterol. Apr 14, 2012; 18(14): 1664-1671
Published online Apr 14, 2012. doi: 10.3748/wjg.v18.i14.1664
Table 1 Clinical and pathological parameters in 155 cases of gastrointestinal stromal tumor
In generalGastric GISTSmall intestinal GIST
Total case1538172
Followed-up cases1046242
Age (yr)
< 50381424
≥ 50644618
Gender
Male724131
Female301911
Tumor size (cm)
< 2110
2.1-5312011
5.1-10462917
> 10241014
Mitotic index
≤ 5/50HPF543123
5-10/50HPF1596
> 10/50HPF332013
Risk grade
Very low risk220
Low risk23149
Intermediate Risk281711
High risk492722
Recurrence22814
Metastasis1578
Survival rate (%)
3-yr disease specific76.64 ± 9.3880.77 ± 11.5073.65 ± 14.24
5-yr disease specific69.05 ± 11.1866.51 ± 17.0661.76 ± 18.30
Table 2 Expressions of 5 molecular markers in gastric and small intestinal gastrointestinal stromal tumor
ProteinGastric GISTsSmall intestinal GISTs
Positive (%)P valuePositive (%)P value
DOD (n = 13)Alive (n = 48)DOD (n = 15)Alive (n = 27)
CD44s5 (38.4)35 (72.9)0.02015 (100)23 (85.2)0.397
MMP-911 (84.6)23 (47.9)0.01811 (73.3)22 (81.5)0.339
TIMP-17 (53.8)22 (45.8)0.6083 (20.0)14 (51.9)0.085
PTEN
< 50%5 (38.5)8 (8.3)0.01411 (73.3)6 (22.2)0.003
≥ 50%8 (61.5)44 (91.7)4 (26.7)21 (77.8)
Ki-67
< 5%7 (53.8)41 (85.4)0.0225 (33.3)24 (88.9)0.0001
≥ 5%6 (46.2)7 (14.6)10 (66.7)3 (11.1)
Table 3 Univariate and multivariate COX regression analyses of molecular markers in gastric gastrointestinal and small intestinal stromal tumor
Univariate analysisMultivariate analysis
OR (95% CI)P valueOR (95% CI)P value
Gastric GIST
PTEN0.23 (0.07-0.74)0.0130.35 (0.10-1.20)0.100
Ki-674.54 (1.45-14.16)0.0092.69 (0.73-9.87)0.130
CD44s0.21 (0.07-0.73)0.0130.43 (0.83-9.98)0.320
PTEN, Ki-67, CD44s5.92 (1.29-27.08)0.0221.35 (0.15-11.80)0.780
MMP-94.22 (1.92-19.31)0.042
TIMP-10.90 (0.29-2.82)0.862
MMP-9/TIMP-10.72 (0.22-2.38)0.586
Small intestinal GIST
Ki-673.29 (1.14-9.46)0.019
PTEN, Ki-674.02 (1.25-16.09)0.021